tirzepatide reaction injection Tirzepatide Side Effects: Common & Rare Reactions Explained allergic reactions to tirzepatide rash

Contact your healthcare provider promptly if you experience any of the following after injection: significant swelling or hardness at the injection site that does not resolve within 48 hours, redness that expands beyond two inches from the injection point, warmth or heat radiating from the injection site combined with pain, any discharge from the injection site including pus or cloudy fluid, fever following injection, severe allergic reaction signs including hives or difficulty breathing, or persistent pain that intensifies rather than improving over 24 hours

Eli Lilly's testing of compounded tirzepatide products found bacterial contamination, high impurity levels, incorrect active ingredients, and in one case, no active ingredient at all

Rotate sites each week

Transitioning from injectable tirzepatide to oral semaglutide or upcoming oral tirzepatide formulations may improve long term adherence

In 2022, the FDA placed tirzepatide on the national drug-shortage list, which under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FDCA) authorized compounding pharmacies to produce the medication to help meet patient needs

A 50-unit syringe holds 0.5 mL total